HCM IV Acquisition Corp Unit HACQU Edges Higher Support at 959 Remains Key Quantum Biopharma Surges 18 Key Breakout Levels to Monitor Elicio Therapeutics ELTX Holds Near Resistance as Therapeutic Pipeline Momentum Builds LanzaTech Global Warrant LNZAW Holds at 001 Limited Movement Reflects Low Activity